Perrigo (PRGO) Divestments (2014 - 2024)

Perrigo (PRGO) posted quarterly Divestments of $10.0 million for Q4 2024, down 95.13% quarter-over-quarter from $205.5 million in Q3 2024.

Perrigo (PRGO) Divestments (2014 - 2024) Analysis & Trends

Perrigo (PRGO) has reported Divestments for 9 consecutive years, with $10.0 million the latest figure, recorded in Q4 2024.

In Q4 2024, Divestments changed N/A year-over-year to $10.0 million; the TTM figure through Dec 2025 stood at $215.5 million (changed 0.0% YoY), while the FY2025 annual figure was $14.4 million, down 93.32% from the prior year.
Divestments declined to $10.0 million in Q4 2024 per PRGO's latest filing, from $205.5 million in the prior quarter.
Across five years, Divestments topped out at $1.5 billion in Q4 2021 and bottomed at -$1.5 billion in Q4 2021.
Historically, Divestments has averaged $14.4 million across 4 years, with a median of $34.4 million in 2022.
Annual changes were most pronounced in 2020 — Divestments plunged 20766.67% — and 2021, when it plunged 695.05%.
Perrigo's Divestments stood at -$187.8 million in 2020, then slumped by 695.05% to -$1.5 billion in 2021, then jumped by 103.93% to $58.7 million in 2022, then sank by 82.96% to $10.0 million in 2024.
Business Quant data shows PRGO's Divestments at $10.0 million in Q4 2024, $205.5 million in Q3 2024, and $58.7 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	4.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	65.64 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Perrigo	1.91 Bn	1.51 Bn	313.90 Mn	-

Download Data